Sort
39,280 grants matching “leukemia”
Cancer In the Jerusalem Perinatal Study
$604,299Columbia University Health Sciences · R01 · FY2004 · CA
Administrative and Informatics
$604,294Thomas J. Kipps · University Of California, San Diego · P01 · FY2014 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES
$604,169University Of Wisconsin Madison · U10 · FY2004 · CA
Development Of P2Y Receptor Ligands
$604,070Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
Predicting Relapse at the Time of Diagnosis in Acute Lymphoblastic Leukemia
$604,026Kara Lynn Davis · Stanford University · R01 · FY2022 · CA
Project 4: Secondary Cancers Among NF1 Cancer Survivors
$603,962Jean Nakamura · Indiana University Indianapolis · U54 · FY2015 · CA
Combination Therapy in B-Chronic Lymphocytic Leukemia
$603,916Neil E Kay · Mayo Clinic Rochester · R01 · FY2010 · CA
Predicting clinical outcome in individuals with small CLL B cell clones
$603,908Neil E Kay · Mayo Clinic Rochester · R01 · FY2018 · CA
The Role of HIF1A-DNMT3A axis in AML1/ETO-Driven Acute MyelogenousLeukemia
$603,874Shujun Liu · Case Western Reserve University · R01 · FY2024 · CA
Pediatric Oncology Clinical Research Training Program
$603,847Baylor College Of Medicine · K12 · FY2003 · CA
Clinical Trial of Ceramide nanoLiposomes in AML
$603,354Mark Kester · University Of Virginia · P01 · FY2020 · CA
Targeting the PNP - SAMHD1 synthetic-lethal combination in cancer
$603,347Vern L. Schramm · Albert Einstein College Of Medicine · R01 · FY2024 · CA
Targeting the PNP - SAMHD1 synthetic-lethal combination in cancer
$603,347Vern L. Schramm · Albert Einstein College Of Medicine · R01 · FY2025 · CA
Validation of prognostic and pathway signatures in lethal prostate cancer
$603,342Phillip G Febbo · University Of California, San Francisco · U01 · FY2011 · CA
Development of a Porcine Model of Ataxia-Telangiectasia
$603,232Christopher Rogers · Exemplar Genetics, Llc · R44 · FY2012 · NS
Phenotype-Genotype Associations with Symptoms During Childhood Leukemia Treatment
$603,111Marilyn J Hockenberry · Duke University · R01 · FY2016 · CA
Molecular Epidemiology of NHL and CLL
$603,041James R Cerhan · Mayo Clinic Rochester · R01 · FY2007 · CA
Development of novel selective Rac inhibitors for refractory leukemias
$603,034David A Williams · Boston Children'S Hospital · R01 · FY2017 · CA
Regulation of the Fanconi Anemia Pathway by Ubiquitination
$603,012Alan David D'andrea · Dana-Farber Cancer Inst · R01 · FY2011 · DK
Targeting IRE-1a/XBP-1 Axis for Control of Chronic GVHD and Leukemia Relapse
$602,961Xue-Zhong Yu · Medical University Of South Carolina · R01 · FY2018 · HL
Regulation of T cell development by HDAC3
$602,939Virginia Smith Shapiro · Mayo Clinic Rochester · R56 · FY2017 · AI
An Academic-Industry Partnership to Advance Functional Genomics for Personalized Oncology.
$602,872Christopher J Kemp · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
Promoting Treatment Adherence in Adolescent Leukemia
$602,850Dennis D Drotar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2012 · CA
Clonal hematopoiesis, mild cognitive impairment and kidney function decline
$602,674Michel Benjamin Chonchol · University Of Colorado Denver · R01 · FY2023 · AG
Predictive Markers in Metastatic Renal Cancer
$602,629Phillip G Febbo · University Of California, San Francisco · R01 · FY2011 · CA